Pivotal trial of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 4-year follow-up
Pavlovich et al, AUA 2023 Annual Meeting (abstract MP73-05), The Journal of Urology (2023)
Profound Medical is committed to research, innovation, improving procedure efficiency and saving lives. We are dedicated to changing the standard of care through quality clinical evidence, working in close partnership with clinicians, physicians, hospitals, and professional associations.
106734B